Can patients' likelihood of benefiting from primary chemotherapy for breast cancer be predicted before commencement of treatment?

Keith Nicholas Ogston, Iain D Miller, Andrew Craig Schofield, A. Spyrantis, E. Pavlidou, T. K. Sarkar, A. W. Hutcheon, S. Payne, Steven Darryll Heys

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Can patients' likelihood of benefiting from primary chemotherapy for breast cancer be predicted before commencement of treatment?'. Together they form a unique fingerprint.

Medicine & Life Sciences